Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage
European Urology Focus · 2024-07 · 10 (4) · 511-513
DOI: 10.1016/j.euf.2024.09.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Urology Focus, 2024-07. Verfasst von Yohann Loriot und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: yohann.loriot@gustaveroussy.fr. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
The level of evidence for the management of prostate cancer progressing after triplet therapy is currently low. Molecular profiling of patients and enrolment in clinical trials are strongly recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: yohann.loriot@gustaveroussy.fr.
- Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Zitieren
APA
Loriot, Y., & Fizazi, K. (2024). Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage. European Urology Focus, 10(4), 511-513. https://doi.org/10.1016/j.euf.2024.09.017
Vancouver
Loriot Y, Fizazi K. Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage. European Urology Focus. 2024;10(4):511-513. doi:10.1016/j.euf.2024.09.017
BibTeX
@article{Loriot2024,
author = {Loriot, Yohann and Fizazi, Karim},
title = {Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage},
journal = {European Urology Focus},
year = {2024},
volume = {10},
number = {4},
pages = {511--513},
doi = {10.1016/j.euf.2024.09.017}
}
EUVIMED